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Background
Ascending aorta (AAo) wall shear stress (WSS) may
drive aorta dilatation in patients with bicuspid aortic
valve (BAV) and b-blockers are first line medical ther-
apy to slow this process. This study sought to determine
if b-blocker therapy reduces AAo WSS in BAV patients.
Methods
Right-left coronary leaflet fusion BAV patients on b-block-
ers (BB+) (n = 30, M:F = 23:7, age: 46 ± 14 years) and not
on b-blockers (BB-) (n=30, M:F = 23:7, age: 46 ± 13 years)
and healthy controls (n=15, age:43±11 years) underwent
time-resolved, 3D phase contrast (4D flow) MRI. Patient
groups were matched by systolic blood pressure (SBP),
degree of aortic stenosis (AS), and AAo diameter (3.9 ±
0.7 vs. 3.9 ± 0.6 cm, p = 0.70). A 3D segmentation of the
thoracic aorta was performed (MIMICS, Materlise,
Belgium). Systolic 3D WSS was calculated in the thoracic
aorta from 4D flow velocity acquisition and a sagittal max-
imum intensity projection (MIP) of WSS was generated.
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Figure 1 Linear Modeling Findings. AAo = ascending aorta; ACE = angiotensin converting enzyme; ARB = angiotensin receptor blocker; WSS =
wall shear stress.
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Systole was defined as five cardiac time frames centered at
the time frame with maximum average aorta velocity. A
region of interest was drawn on the MIP from the sinus of
Valsalva to the brachiocephalic artery to define the AAo,
and this region was further subdivided into anterior and
posterior segments. Max and mean systolic AAo WSS were
extracted from each segment. Peak systolic AAo velocity
was also measured. Quantitative results were compared
with one-way analysis of variance and linear modeling was
performed.
Results
Maximum and mean WSS were not reduced in the BB
+ group compared BB- patients in either the anterior
AAo (maximum: 1.49±0.47N/m2 vs. 1.38±0.49N/m2,
p=0.99, mean: 0.76±0.2N/m2 vs. 0.74±0.18N/m2, p=1.00)
or posterior AAo (maximum: 1.45±0.42N/m2 vs. 1.39±
0.58N/m2, p=1.00; mean: 0.65±0.16N/m2 vs. 0.63±
0.16N/m2, p=1.00). Both patient groups had higher max-
imum and mean WSS relative to the control group
(p=0.001 to p=0.04). AAo peak velocity was elevated in
patients compared to controls (p<0.01) but not signifi-
cantly different for BB+ vs. BB- groups (p=0.42). Linear
models identified significant relationships between aortic
stenosis severity and increased maximum WSS
(b=0.186, p=0.007) and between diameter at the sinus of
Valsalva and reduced mean WSS (b=-0.151, p=0.045).
Conclusions
BB therapy does not reduce systolic WSS or peak velocity
and does not impact WSS asymmetry in the AAo of right-
left fusion BAV patients. Further longitudinal studies are
needed to clarify the impact of dose and duration of BB
therapy on aortopathy.
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Figure 2 Systolic wall shear stress (WSS) maximum intensity projections (MIPs) in BAV patients with no aortic stenosis (AS), moderate AS, and
severe AS from the BB+ and BB- group compared to a representative control subject.
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